吸入沙美特罗替卡松治疗支气管哮喘慢性持续期的疗效与安全性研究.pdfVIP

150 北方药学2016 年第 13 卷第7 期 吸入沙美特罗替卡松治疗支气管哮喘慢性持续期的疗效与安全 性研究 顾文东 吕卫兵 赵勤峰(苏州市吴中人民医院呼吸内科苏州 215128) 摘要:目的:研究吸入沙美特罗替卡松治疗对支气管哮喘慢性持续期的疗效表现，围绕现实病案资料，得出有效结论。方法:随机选 择某院2010 年2 月 -2016 年 2 月收治的 80 例支气管哮喘慢性持续期患者，对照纽 30 例进行常规治疗;研究纽 50 例采用吸入沙 美特罗替卡松治疗，对比两组疗效。结采:研究组呼吸频率、心率、血氧饱和度等体征状态改善情况优于对照组，显效38 例、好转 8 例，一般 3 1f1 、无效 l 例，治疗有效率为 929毛;对照纽显效 12 例，好转 8 例，一般 7 例，无效 3 例，治疗有效率 66.67% ，差异具有统 计学意义(P0.05) 。结论:吸入沙关特罗替卡松治疗可以在疗效上弥补传统治疗技术的缺陷和不足，稳定支气管哮喘慢性持续期 患者体征状态及表现，促进患者呼吸质量的提升，综合提升临床治疗的疗效与安全性。 关键词:沙美特罗替卡松支气管哮喘慢性持续期疗效与安全性 中图分类号:R562.2+5 文献标识码:8 文章编号:1672-8351(2016)07-0150-02 Inhaled sabneterol assigned trea伽lent of bronchial asthma patients witb cbronic duration of efficacy and safety studies Gu Wendong Lv Weibing Zhao Qinfeng (Respiratory Medicine of Suzhou Wuzhong Peoples Hospital , Jiangsu 215128 China). Abstract:Objective:To. ,study the inhaled salmeterol assigned the curative effect of treatment in patients with chronic bronchial asthma duration performance , around the reality of medical record information , draw valid conclusions. Methods: Randomly selected a hospital in February 2010 - February 2016 treated 80 cases of bronchial asthma patients with chronic duration , the conventional treatment control group 30 cases; Team of 50 cases with inhaled salmeterol assigned treatment , compared two groups of curative effect. Results: Team , breathing rate , heart rate , blood oxygen saturation and other signs of status , to improve the situation is better than that of control group , 38 cases , improvement in 8 cases were markedly effective , generally 3 cases , 1 had no effect , the treatment effective rate was 92%; Control group , 12 cases were cured , 8 cases , 7 cases , generally ineffective in 3 patients , treatment effectiveness 66.679岛，由e difference statistically sig